Chandra Bhagat Pharma logo

542934 - Chandra Bhagat Pharma Share Price

₹43 0.0  0.0%

Last Trade - 23/11/20

Sector
Healthcare
Size
Micro Cap
Market Cap £3.30m
Enterprise Value £5.73m
Revenue £9.55m
Position in Universe 2143rd / 3024
Bullish
Bearish
Unlock 542934 Revenue
Momentum
Relative Strength (%)
1m -14.0%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -25.9%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 897.9 970.6 1,063 939.8 +1.5%
+56.6 -39.5 -33.7
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 September 2020, ChandraBhagat Pharma Ltd revenues totaled RS223.6M. Net incometotaled to RS345K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

542934 Revenue Unlock 542934 Revenue

Net Income

542934 Net Income Unlock 542934 Revenue

Normalised EPS

542934 Normalised EPS Unlock 542934 Revenue

PE Ratio Range

542934 PE Ratio Range Unlock 542934 Revenue

Dividend Yield Range

542934 Dividend Yield Range Unlock 542934 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
542934 EPS Forecasts Unlock 542934 Revenue
Profile Summary

Chandra Bhagat Pharma Ltd, formerly Chandra Bhagat Pharma Pvt. Ltd, is an India-based medicine company. The Company is engaged in the business of marketing of pharmaceutical formulation and products in domestic and international market through its distribution network and sales force under its own brand. It provides a range of products portfolio of pharmaceutical formulation including intravenous (IV) and intramuscular (IM) range injections, dry syrup, tablets and capsules which are supplied to hospital and health care center for critical diseases to cater the domestic and export market. The Company also provides products under therapeutic categories for formulations such as anti-cancer (Oncology), antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, and neurology. It is also engaged in promoting and marketing of Active Pharmaceuticals Ingredients (APIs) in India.

Directors
Last Annual March 31st, 2020
Last Interim September 30th, 2020
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Bombay Stock Exchange
Shares in Issue 7,545,056
Free Float (0.0%)
Eligible for
ISAs
SIPPs
542934 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 542934
Upcoming Events for 542934
Frequently Asked Questions for Chandra Bhagat Pharma
What is the Chandra Bhagat Pharma share price?

As of 23/11/20, shares in Chandra Bhagat Pharma are trading at ₹43, giving the company a market capitalisation of £3.30m. This share price information is delayed by 15 minutes.

How has the Chandra Bhagat Pharma share price performed this year?

Shares in Chandra Bhagat Pharma are currently trading at ₹43 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Chandra Bhagat Pharma price has moved by % over the past year.

What are the analyst and broker recommendations for Chandra Bhagat Pharma?

There are no analysts currently covering Chandra Bhagat Pharma.

When will Chandra Bhagat Pharma next release its financial results?

Chandra Bhagat Pharma is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Chandra Bhagat Pharma dividend yield?

Chandra Bhagat Pharma does not currently pay a dividend.

Does Chandra Bhagat Pharma pay a dividend?

Chandra Bhagat Pharma does not currently pay a dividend.

When does Chandra Bhagat Pharma next pay dividends?

Chandra Bhagat Pharma does not currently pay a dividend.

How do I buy Chandra Bhagat Pharma shares?

To buy shares in Chandra Bhagat Pharma you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Chandra Bhagat Pharma?

Shares in Chandra Bhagat Pharma are currently trading at ₹43, giving the company a market capitalisation of £3.30m.

Where are Chandra Bhagat Pharma shares listed? Where are Chandra Bhagat Pharma shares listed?

Here are the trading details for Chandra Bhagat Pharma:

Country of listing: India
Exchange: BSE
Ticker Symbol: 542934
What kind of share is Chandra Bhagat Pharma?

Based on an overall assessment of its quality, value and momentum, Chandra Bhagat Pharma is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Chandra Bhagat Pharma share price forecast 2020?

We were not able to load any forecast data for Chandra Bhagat Pharma.

How can I tell whether the Chandra Bhagat Pharma share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Chandra Bhagat Pharma. Over the past six months, the relative strength of its shares against the market has been -32.75%. At the current price of ₹43, shares in Chandra Bhagat Pharma are trading at -1.48% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Chandra Bhagat Pharma PE Ratio?

The Chandra Bhagat Pharma PE ratio based on its reported earnings over the past 12 months is 78.18. The shares are currently trading at ₹43.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Chandra Bhagat Pharma?

We were unable to find the directors for Chandra Bhagat Pharma.

Who are the major shareholders of Chandra Bhagat Pharma?

Here are the top five shareholders of Chandra Bhagat Pharma based on the size of their shareholding:

Chandravadan (Hemant Bhagat) Individual Investor
Percentage owned: 38.52% (2.91m shares)
Bhagat (Chitra Hemant) Individual Investor
Percentage owned: 16.34% (1.23m shares)
Bhagat (Pranav Hemant) Individual Investor
Percentage owned: 8.72% (658k shares)
Goenka Business & Finance, Ltd. Corporation
Percentage owned: 4.37% (330k shares)
Hemant C Bhagat Huf Individual Investor
Percentage owned: 1.97% (149k shares)
Similar to 542934
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.